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Nitric oxide (NO) mediates both physiological and pathological processes. 1, 2 In addition to cardiovascular signaling, NO has been invoked to play a neurochemical role in learning and memory, and it is a powerful necrotic agent wielded by macrophages of the immune system. Whereas considerable effort has been invested to develop metal-based [3] [4] [5] and other 6, 7 probes for detecting nitric oxide, there has been significantly less progress in the synthesis of platforms capable of detecting other reactive nitrogen species (RNS). 8 Of the nitrogen oxides relevant to biology, nitroxyl (HNO), the one electron reduced, protonated analog of nitric oxide, 9 is among the least thoroughly investigated. 10 Interest in nitroxyl has grown with the accumulation of evidence that HNO, which has a pK a of 11.4 and exists primarily in the protonated form under physiological conditions, 9 displays important biological roles with potential pharmacological applications distinct from those of nitric oxide. [11] [12] [13] For example, HNO reacts directly with thiols, 14 is resistant to scavenging by superoxide, 15 and can activate voltage-dependent K + channels in mammalian vascular systems. 16, 17 Moreover, biochemical studies suggest that HNO can be formed directly from nitric oxide synthase under appropriate conditions 10, 18 and that NO and HNO may be able to interconvert in the presence of superoxide dismutase (SOD). 19 Despite accumulating evidence of the biological importance of HNO, studies have been hampered by the lack of a biologically compatible probe for the molecule. Only recently have chemical systems capable of discerning HNO from NO been reported, but the constructs are not suitable for work with biological samples. 20, 21 Properties required for selective nitroxyl detection using fluorescence methods under physiologically relevant conditions include selectivity over other reactive nitrogen species (RNS) and downstream NO oxidation products, compatibility with living biological samples, water solubility, and membrane permeability. Additionally, incorporation of a signaling moiety with relatively long-wavelength absorption and emission properties is needed to avoid unintended cellular damage by high-energy radiation and to minimize innate biological autofluorescence. BOT1 (Scheme 1) juxtaposes a BODIPY reporter site, which has optical properties that are well suited for cellular imaging experiments, 22 with a tripodal dipyridylamine appended receptor via a triazole bridge. The tripodal metal-binding site of BOT1 comprises a tertiary nitrogen bearing two 2-pyridylmethyl substituents. The third arm of the tripod is afforded by the triazole formed upon coupling of an alkyl azide with a terminal alkyne. 23 Accordingly, the triazole arm completes the tripodal coordination environment engendered by the N-(triazolylmethyl)-N,N-dipicolyl framework while simultaneously providing a rigid spacer between the BODIPY reporter and chelating ligand. This design serves to minimize the distance between fluorophore and metal binding site, thereby assuring strong fluorescence quenching in the probe off-state. The triazole arm was installed by the copper(I) mediated clickcoupling of alkyne 1 with the azide produced upon in situ displacement of Clfrom TM-BODIPY-CH 2 Cl by NaN 3 .
The photophysical properties of BOT1 were assessed under simulated physiological conditions (50 mM PIPES, 100 mM KCl, pH = 7.0). The probe displays optical properties typical of a BODIPY chromophore, with an absorption band in the visible region centered at 518 nm (ε = 30,900 ± 960 M -1 cm -1 ). Excitation into these bands produces an emission profile with a maximum at 526 nm, and Φ fl = 0.12 ( Fig. 1 ). Upon addition of one equiv of CuCl 2 to a solution of BOT1, the fluorescence intensity decreased by ~12-fold (Φ fl = 0.01), which we attribute to photoinduced electron transfer (PET) from the BODIPY singlet excited state to the bound Cu 2+ ion ( Fig. S1 , Supporting Information). The positive ion electrospray mass spectrum of this species displayed a peak with m/z = 638.3, which corresponds to that of [Cu II (BOT1)Cl] + (calcd. m/z = 638.2) ( Fig. S2 ). Titration of BOT1 with CuCl 2 , produced the series of emission changes displayed in Fig. S3 , with an apparent dissociation constant of K d = 3.0 ± 0.1 μM (Fig. S3) , as calculated by a Benesi-Hildebrand analysis. Photophysical data recorded for BOT1 and Cu II [BOT1] are available (Table  S1 ). Analytically pure [Cu(BOT1)Cl]Cl·acetone has been obtained.
Treatment of a 1 µM solution of Cu II [BOT1] with 1000 equivalents of cysteine restored the emission to that of uncomplexed BOT1, owing to reduction of the paramagnetic Cu 2+ ion. The positive ion electrospray mass spectrum of this reduced species showed a peak with m/z = 604.3, which corresponds to the cationic [Cu I (BOT1)] + complex (calcd m/z = 604.0) ( Fig S4) . A solution of Cu II [BOT1] in buffered aqueous solution was treated with excess Angeli's Salt, which generates an equimolar ratio of nitroxyl (HNO) and nitrite under physiological conditions. 24 A 4.3 ± 0.6 fold increase in emission was observed, demonstrating fast HNO detection with significant turn-on under physiologically relevant conditions (Fig. 1) . Emission turn-on was visualized Scheme 1. Synthesis of BODIPY-triazole 1 (BOT1) using as little as 50 µM Angeli's salt. Cu II [BOT1] displayed a negligible change in emission when treated with a 1000-fold excess of NaNO 2 , indicating that the turn-on response induced by Angeli's Salt is due to HNO production and not the NO 2 side product. HNO reacts with SODCu II to generate NO and reduced SODCu I . 19 A similar reaction appears to occur with Cu II [BOT1], because treatment of the complex with Angeli's salt results in production of NO (g), as observed by EI-MS ( Fig S5) , concomitant with reduction of the paramagnetic Cu 2+ complex to give the same [Cu I (BOT1)] + species observed by ESI-MS that is obtained upon reduction with cysteine ( Fig S4) . EPR spectroscopy provides further evidence for reduction of the paramagnetic Cu II [BOT1] complex by HNO ( Fig S6) . The emission response for Cu II [BOT1] is highly specific for HNO over other reactive species present in the biological milieu. Apart from NO 2 -, other RNS and ROS including NO, NO 3 -, ONOO -, H 2 O 2 , OClfailed to induce significant emission enhancement of the Cu II [BOT1] complex (Fig. 1b ). The negligible emission enhancement observed upon treatment of Cu II [BOT1] with saturated solutions of buffered NO is especially noteworthy and makes this system potentially valuable for studying the proposed disparate roles of NO and HNO in biology.
We next assessed the ability of Cu II [BOT1] to operate in live cells. HeLa cells were incubated with 1 µM Cu II [BOT1] (1 h, 37 °C). Under these conditions, cells show only faint intracellular fluorescence ( Fig. 2a ). Addition of 200 µM Angeli's salt increased the observed intracellular red fluorescence over the course of 10 min, consistent with an HNO-induced emission response. No change in emission intensity was observed for the same time period for cultures to which Angeli's salt was not added (Fig S7) . Moreover, treatment of HeLa cells incubated with the Cu II [BOT1] probe with the NO donor diethylamine NONOate (200 µM) did not enhance the observed fluorescence ( Figure S8 ). Addition of exogenous cysteine to cells impregnated with Cu II [BOT1] induced a rapid increase in observed emission ( Fig  S9) , indicating that exogenous cysteine can reduce Cu 2+ (vide supra) from some intracellular store and liberate labile Cu + . A related approach to image pools of labile Cu + using ascorbate as an external reductant has been described. 25 The lack of a substantial fluorescent signal following addition of Cu II [BOT1] to cells assures that normal levels of intracellur cysteine and other thiols are insufficient to produce the fluorescent response that we observe for HNO.
Cu II The synthesis, photophysical properties, and a biological application of BODIPY-triazole 1 (BOT1) are described. BOT1 juxtaposes a BODIPY fluorophore with a tripodal ligand platform via a triazole bridge. The triazole linker is afforded by azidealkyne "click" chemistry and comprises the third arm of the tripodal architecture. BOT1 binds Cu 2+ in aqueous solution to form a Cu II [BOT1] complex in which emission from the BODIPY moiety is efficiently quenched. This complex exhibits a prompt turnon response when exposed to nitroxyl, and this emission response is specific to HNO over other RNS and ROS. Notably, Cu II [BOT1] does not fluoresce in the presence of nitric oxide, making this system the first discrete molecular probe capable of detecting HNO over NO under physiologically relevant conditions. Fluorescence microscopy experiments establish that Cu II [BOT1] is membrane-permeable and can successfully signal the presence of HNO in live cells.
